Evidence of an association between use of anti-microbial agents in food animals and anti-microbial resistance among bacteria isolated from humans and the human health consequences of such resistance.

Several lines of evidence indicate that the use of anti-microbial agents in food animals is associated with anti-microbial resistance among bacteria isolated from humans. The use of anti-microbial agents in food animals is most clearly associated with anti-microbial resistance among Salmonella and Campylobacter isolated from humans, but also appears likely among enterococci, Escherichia coli and other bacteria. Evidence is also accumulating that the anti-microbial resistance among bacteria isolated from humans could be the result of using anti-microbial agents in food animals and is leading to human health consequences. These human health consequences include: (i) infections that would not have otherwise occurred and (ii) increased frequency of treatment failures and increased severity of infection. Increased severity of infection includes longer duration of illness, increased frequency of bloodstream infections, increased hospitalization and increased mortality. Continued work and research efforts will provide more evidence to explain the connection between the use of anti-microbial agents in food animals and anti-microbial-resistant infections in humans. One particular focus, which would solidify this connection, is to understand the factors that dictate spread of resistance determinants, especially resistant genes. With continued efforts on the part of the medical, veterinary and public health community, such research may contribute to more precise guidelines on the use of anti-microbials in food animals.

[1]  Peter Gerner-Smidt,et al.  Excess Mortality Associated with Antimicrobial Drug-Resistant Salmonella Typhimurium , 2002, Emerging infectious diseases.

[2]  W. Witte,et al.  Antibiotics in animal feed. , 2000, Acta veterinaria Scandinavica. Supplementum.

[3]  F. Aarestrup,et al.  Quinolone-resistant Campylobacter Infections: Risk Factors and Clinical Consequences , 2004, Emerging infectious diseases.

[4]  L. Hutwagner,et al.  Prior antimicrobial agent use increases the risk of sporadic infections with multidrug-resistant Salmonella enterica serotype Typhimurium: a FoodNet case-control study, 1996-1997. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  M. Barza Potential mechanisms of increased disease in humans from antimicrobial resistance in food animals. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  K. Travers,et al.  Excess infections due to antimicrobial resistance: the "Attributable Fraction". , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  D. Wareing,et al.  Decreased susceptibility to ciprofloxacin in outbreak-associated multiresistant Salmonella typhimurium DT104 , 2000, Veterinary Record.

[8]  K. Mølbak,et al.  A case–control study of risk factors for sporadic campylobacter infections in Denmark , 2003, Epidemiology and Infection.

[9]  R. Willems,et al.  Different Levels of Genetic Homogeneity in Vancomycin-Resistant and -Susceptible Enterococcus faecium Isolates from Different Human and Animal Sources Analyzed by Amplified-Fragment Length Polymorphism , 2002, Antimicrobial Agents and Chemotherapy.

[10]  N. Marano,et al.  Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection. , 2004, The Journal of infectious diseases.

[11]  M. Bohnhoff,et al.  Enhanced susceptibility to Salmonella infection in streptomycin-treated mice. , 1962, The Journal of infectious diseases.

[12]  T. Barrett,et al.  Emergence of Multidrug-Resistant Salmonella enterica Serotype Newport Infections Resistant to Expanded-Spectrum Cephalosporins in the United States , 2003 .

[13]  R. Nagaraj,et al.  Structure-Function Relationship Studies on the Frog Skin Antimicrobial Peptide Tigerinin 1: Design of Analogs with Improved Activity and Their Action on Clinical Bacterial Isolates , 2002, Antimicrobial Agents and Chemotherapy.

[14]  C. Chiu,et al.  EMERGENCE OF FLUOROQUINOLONE RESISTANCE IN SALMONELLA ENTERICA SEROTYPE CHOLERAESUIS THE EMERGENCE IN TAIWAN OF FLUOROQUINOLONE RESISTANCE IN SALMONELLA ENTERICA SEROTYPE CHOLERAESUIS , 2002 .

[15]  R. Tauxe,et al.  Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: implications for the use of fluoroquinolones in food animals. , 2000, Microbial drug resistance.

[16]  S. Solomon,et al.  Health and economic impacts of antimicrobial resistance. , 1987, Reviews of infectious diseases.

[17]  M. Swartz Human diseases caused by foodborne pathogens of animal origin. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  S. Levy,et al.  Changes in intestinal flora of farm personnel after introduction of a tetracycline-supplemented feed on a farm. , 1976, The New England journal of medicine.

[19]  H. Endtz,et al.  Fluoroquinolone resistance in Campylobacter spp isolated from human stools and poultry products , 1990, The Lancet.

[20]  Ronald N. Jones,et al.  Molecular Analysis of Tn1546 inEnterococcus faecium Isolated from Animals and Humans , 1998, Journal of Clinical Microbiology.

[21]  P. Fey,et al.  Ceftriaxone-resistant salmonella infection acquired by a child from cattle. , 2000, The New England journal of medicine.

[22]  N. Marano,et al.  Fluoroquinolone-resistant Campylobacter infections: eating poultry outside of the home and foreign travel are risk factors. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  W. Witte,et al.  Spread of plasmid‐mediated nourseothricin resistance due to antibiotic use in animal husbandry , 1986, Journal of basic microbiology.

[24]  E. K. Maloney,et al.  Increase in antimicrobial-resistant Salmonella infections in the United States, 1989-1990. , 1994, The Journal of infectious diseases.

[25]  J. Crump,et al.  Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  L. Unicomb,et al.  Fluoroquinolone Resistance in Campylobacter Absent from Isolates, Australia , 2003, Emerging infectious diseases.

[27]  M. S. St. Louis,et al.  Chloramphenicol-resistant Salmonella newport traced through hamburger to dairy farms. A major persisting source of human salmonellosis in California. , 1987, The New England journal of medicine.

[28]  M. Zervos,et al.  Molecular Characterization of Gentamicin-Resistant Enterococci in the United States: Evidence of Spread from Animals to Humans through Food , 2003, Journal of Clinical Microbiology.

[29]  T. Jones,et al.  Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. , 2005, The Journal of infectious diseases.

[30]  F. Aarestrup,et al.  Is It Time To Change Fluoroquinolone Breakpoints for Salmonella spp.? , 2003, Antimicrobial Agents and Chemotherapy.

[31]  J. Besser,et al.  Quinolone-ResistantCampylobacter jejuniInfections in Minnesota, 1992–1998 , 1999 .

[32]  F. Aarestrup,et al.  An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104. , 1999, The New England journal of medicine.